Fiducial Markers Market
Fiducial Markers Market By Product Type (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers), By Modality (CT/CBCT, MRI, Ultrasound), By Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer), And By End User (Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers) - Forecast Year 2024 – 2031
Healthcare // Medical Devices
The global fiducial markers market is foreseen to grow at 4.1%, from USD 112.3 Million in 2021 to
USD 154.9 Million in 2029. Rise in adoption of fiducial markers in radiology,
and technological advancements in the field of Fiducial Markers.
Adoption of cutting-edge
technologies in hospitals and medical sectors has boosted the growth of manufacturers
of fiducial markers.
COVID-19 Impact on Global Fiducial Markers
Market
The fiducial markers is the supply line for organ transplantation, helping treat patients.
The continuous spread of COVID-19 has caused a massive decrease in organ
donation, thus negatively impacting the aspects of Fiducial Markers in recent
years. However, government and private entities have various strategies to
deliver proper care to patients during organ transplantation.
Market Segmentation
For the purpose
of this report, the global Fiducial Markers market is segmented on the basis of
product type, modality type, cancer type, end user and region:
|
Product Type Outlook (Revenue, USD million;
2018-2029) |
||
|
Metal-based Markers |
Metal-based Markers |
|
|
|
Pure Gold |
|
|
|
Gold Alloys |
|
|
|
Other Metal-based Markers |
|
|
Polymer-based Markers |
||
|
Other Fiducial Markers |
||
|
Modality Type Outlook (Revenue, USD
million; 2018-2029) |
||
|
CT/CBCT |
|
|
|
MRI |
|
|
|
Ultrasound |
|
|
|
Radiotherapy |
|
|
|
Cancer Type Outlook (Revenue, USD million;
2018-2029) |
||
|
Prostate Cancer |
|
|
|
Lung Cancer |
|
|
|
Breast Cancer |
|
|
|
Gastric Cancer |
|
|
|
Other Cancers |
|
|
|
End User Outlook (Revenue, USD million;
2018-2029) |
||
|
Hospitals & Outpatient Facilities |
|
|
|
Independent Radiotherapy Centers |
|
|
|
Cancer Research Centers |
|
|
Product Type Outlook:
On the basis of
product type, the market is segmented into metal-based markers, polymer-based
markers, other fiducial markers.
Figure 1 - Fiducial Markers Market, By Product
Type (Market Size And Forecast By Value - USD Million, 2021 & 2029)
Modality Outlook:
On the basis of
modality, the market is segmented into CT/CBCT, MRI, ultrasound, radiotherapy.
Figure 2 - Modality Outlook (Revenue, USD
Million, 2021)
Cancer Type Outlook:
On the basis of
cancer type, the market is segmented into prostate cancer, lung cancer, breast
cancer, gastric cancer, other cancers.
Figure 3 - Fiducial Markers Market, By Cancer
Type (Market Size and Forecast by Value - USD Million, 2021 & 2029)
End User Outlook:
On the basis of
end user, the market is segmented into hospitals & outpatient facilities,
independent radiotherapy centers, cancer research centers.
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 4 - Fiducial Markers Market: Regional
dynamics
North America held the largest market share in 2021 due to the growing public-private
initiatives and adoption of radiotherapy procedures in the region. Moreover, rising
cases of cancer is also one of the factors driving the market.
The Asia Pacific is anticipated to witness the fastest growth over the
forecast period owing to the surge in patient population and favorable
government initiatives in emerging nations over the foreseen period.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. The key highlight is:
· In October 2021, Roper
Technologies, Inc. announced an agreement to sell its CIVCO Radiotherapy
business to an affiliate of Blue Wolf Capital Partners LLC, thus retaining its
CIVCO Medical Solutions business, by continuing its operate independently.
Some of the
prominent players in the Fiducial Markers market include:
· Beekley Corporation
· Best Medical
International, Inc.
· Boston Scientific
Corporation
· Carbon Medical
Technologies
· CIVCO Radiotherapy
· Eckert &
Ziegler
· IBA
· Innomedicus Ag
· Innovative Oncology
Solutions
· IZI Medical
Products
· JJ-Medtech
· Meditronix
Corporation
· Medtronic
· Nanovi A/S
· Naslund Medical AB
· QFIX
· QlRad Inc.
· Seedos Ltd
· Stellar Medical
· Varian Medical
Systems, Inc.
Global Fiducial Markers Market Report Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Million |
|
Revenue
forecast in 2029 |
USD 154.9 Million |
|
Growth
Rate |
CAGR of 4.1%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR from
2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product Type, Modality, Cancer Type, Application,
End User, Region |
|
Key
companies profiled |
CIVCO
Radiotherapy, Boston Scientific Corporation, IZI Medical Products |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S., Canada,
Germany, U.K., France, Italy, Spain, India, Japan, China, Australia, South
Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
|
Chapter 1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for Study |
|
|
Chapter 2. Research Methodology |
|
|
2.1. Research Sources |
|
|
2.1.1. Primary |
|
|
2.1.2. Secondary |
|
|
2.2. Market Size Estimation |
|
|
Chapter 3. Executive Summary |
|
|
3.1. Summary Snapshot Market Size and Forecast, 2018-2029 |
|
|
3.2. Fiducial Markers Market Share by Product Type, 2021 vs 2029 (USD
Million) |
|
|
3.3. Fiducial Markers Market Share by Modality, 2021 vs 2029 (USD
Million) |
|
|
3.4.
Fiducial Markers Market Share by Cancer Type, 2021 vs 2029 (USD Million) |
|
|
3.5. Fiducial Markers Market Share by End User, 2021 vs 2029 (USD
Million) |
|
|
3.5. Fiducial Markers Market Share by Region, 2021 vs 2029 (USD
Million) |
|
|
Chapter 4. Key Insights |
|
|
Chapter 5. Fiducial Markers Market
Segmentation & Impact Analysis |
|
|
5.1. Fiducial Markers Market Indicators Analysis |
|
|
5.1.1. Market Drivers Analysis |
|
|
5.1.1.1. Growing Incidence
of Cancer |
|
|
5.1.1.2. Improving
Reimbursement Scenario |
|
|
5.1.1.3. Rising
Awareness on Radiotherapy |
|
|
5.1.1.4. Rising
Investments and Funding for Cancer Research |
|
|
5.1.2. Market Restraint
Analysis |
|
|
5.1.2.1. Lack of
Adequate Healthcare Infrastructure and Premium Pricing of Modalities |
|
|
5.1.2.2. Alternative
Therapies and High Marker Costs |
|
|
5.1.3. Market Opportunity Analysis |
|
|
5.1.3.1. Rising
Adoption of Fiducial Markers in Emerging Economies |
|
|
5.2. Regulatory Analysis |
|
|
5.2.1. North America |
|
|
5.2.1.1. U.S. |
|
|
5.2.1.2. Canada |
|
|
5.2.2. Europe |
|
|
5.2.2. Asia Pacific |
|
|
5.2.2.1. India |
|
|
5.2.2.2. Japan |
|
|
5.2.2.3. China |
|
|
5.3.
Technological Insights |
|
|
5.4. COVID-19 Impact analysis on Fiducial Markers Market |
|
|
5.5. Porter’s Five Forces Analysis |
|
|
5.5.1. Bargaining Power of Buyers/Consumers |
|
|
5.5.2. Bargaining Power of Suppliers |
|
|
5.5.3. Threat of New Entrants |
|
|
5.5.4. Threat of Substitute Products |
|
|
5.5.5. Intensity of Competitive Rivalry |
|
|
5.6.
Competitive Metric Space Analysis |
|
|
Chapter 6. Fiducial Markers Market, By
Product Type (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
|
6.1. Fiducial Markers Market, By Product Type (Market Size and
Forecast by Value - USD Million, 2021 & 2029) |
|
|
6.1.1. Metal-based Markers |
|
|
6.1.1.1. Metal-based Markers Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
6.1.1.2. Metal-based Markers Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.1.3. Pure Gold |
|
|
6.1.1.3.1. Pure Gold Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.1.3.2.
Pure Gold Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.1.4. Gold Alloys |
|
|
6.1.1.4.1. Gold Alloys Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.1.4.2. Gold Alloys Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.1.5. Other Metal-based Markers |
|
|
6.1.1.5.1. Other Metal-based Markers Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
6.1.1.5.2. Other Metal-based Markers Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
6.1.2. Polymer-based Markers |
|
|
6.1.2.1.
Polymer-based Markers Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.2. Polymer-based
Markers Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.3. Other Fiducial Markers |
|
|
6.1.3.1. Other
Fiducial Markers Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.3.2.
Other Fiducial Markers Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
Chapter 7. Fiducial Markers Market, By
Modality (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
|
7.1. Fiducial Markers Market, By Modality (Market Size and Forecast by
Value - USD Million, 2021 & 2029) |
|
|
7.1.1. CT/CBCT |
|
|
7.1.1.1. CT/CBCT Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.1.2. CT/CBCT Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
7.1.2. MRI |
|
|
7.1.2.1. MRI Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.2.2. MRI Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
7.1.3. Ultrasound |
|
|
7.1.3.1. Ultrasound
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.3.2. Ultrasound
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.4. Radiotherapy |
|
|
7.1.4.1. Radiotherapy
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.4.2.
Radiotherapy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
Chapter 8. Fiducial Markers Market, By
Cancer Type (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
|
8.1. Fiducial Markers Market, By Cancer Type (Market Size and Forecast
by Value - USD Million, 2021 & 2029) |
|
|
8.1.1. Prostate Cancer |
|
|
8.1.1.1. Prostate Cancer Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
8.1.1.2. Prostate Cancer Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
8.1.2. Lung Cancer |
|
|
8.1.2.1. Lung Cancer Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
8.1.2.2. Lung Cancer Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
8.1.4. Gastric Cancer |
|
|
8.1.4.1. Gastric
Cancer Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.4.2. Gastric
Cancer Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
8.1.5. Other Cancers |
|
|
8.1.5.1. Other
Cancers Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.5.2. Other Cancers
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 9. Fiducial Markers Market, By
End User (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
|
9.1. Fiducial Markers Market, By End User (Market Size and Forecast by
Value - USD Million, 2021 & 2029) |
|
|
9.1.1. Hospitals &
Outpatient Facilities |
|
|
9.1.1.1. Hospitals
& Outpatient Facilities Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
9.1.1.2. Hospitals
& Outpatient Facilities Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
9.1.2. Independent Radiotherapy
Centers |
|
|
9.1.2.1. Independent
Radiotherapy Centers Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
9.1.2.2. Independent
Radiotherapy Centers Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
9.1.3. Cancer Research Centers |
|
|
9.1.3.1. Cancer
Research Centers Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
9.1.3.2. Cancer
Research Centers Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
Chapter 10. Fiducial Markers Market, By
Region (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
|
10.1. Fiducial Markers Market, By Region (Market Size and Forecast by
Value - USD Million, 2021 & 2029) |
|
|
10.2. North America |
|
|
10.2.1. North America Fiducial
Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.2.2. North America Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.2.3. North America Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.2.4. North America Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.2.5. North America Fiducial
Markers Market, By Country, 2018-2029 (USD Million) |
|
|
10.2.6. U.S. |
|
|
10.2.6.1. U.S.
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.2.6.2. U.S.
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.2.6.3.
U.S. Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.2.6.3. U.S. Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.2.7. Canada |
|
|
10.2.7.1. Canada
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.2.7.2. Canada
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.2.7.3. Canada
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.2.7.3. Canada
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3. Europe |
|
|
10.3.1. Europe Fiducial Markers
Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.2. Europe Fiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.3. Europe Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.4. EuropeFiducial Markers
Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.5. Europe Fiducial Markers
Market, By Country, 2018-2029 (USD Million) |
|
|
10.3.6. Germany |
|
|
10.3.6.1. Germany
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.6.2. Germany
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.6.3. Germany
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.6.3. Germany
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.7. U.K. |
|
|
10.3.7.1. U.K.
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.7.2. U.K. Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.7.3. U.K.
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.7.3. U.K.
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.8. France |
|
|
10.3.8.1. France
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.8.2. France
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.8.3. France
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.8.3. France Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.9. Spain |
|
|
10.3.9.1. Spain
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.9.2. Spain
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.9.3. Spain
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.9.3. Spain
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.10. Italy |
|
|
10.3.10.1. Italy
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.10.2. Italy Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.10.3. Italy
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.10.3. Italy
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.11. Rest of Europe |
|
|
10.3.11.1. Rest
of Europe Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.3.11.2. Rest
of Europe Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.3.11.3. Rest
of Europe Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.3.11.3. Rest
of Europe Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4. Asia Pacific |
|
|
10.4.1. Asia Pacific Fiducial
Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.2. Asia Pacific Fiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.3. Asia Pacific Fiducial
Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.4. Asia Pacific Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.5. Asia Pacific Fiducial
Markers Market, By Country, 2018-2029 (USD Million) |
|
|
10.4.6. India |
|
|
10.4.6.1. India
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.6.2. India Fiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.6.3. India
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.6.3. India
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.7. Japan |
|
|
10.4.7.1. Japan
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.7.2. Japan
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.7.3. Japan
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.7.3. Japan
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.8. China |
|
|
10.4.8.1. China
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.8.2. China Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.8.3. China
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.8.3. China Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.9. South Korea |
|
|
10.4.9.1. South
Korea Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.9.2. South
Korea Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.9.3. South
Korea Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.9.3. South
Korea Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.10. Australia |
|
|
10.4.10.1. Australia
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.10.2.
Australia Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.10.3.
Australia Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.10.3.
Australia Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.11. Rest of Asia Pacific |
|
|
10.4.11.1. Rest
of Asia Pacific Fiducial Markers Market, By Product Type, 2018-2029 (USD
Million) |
|
|
10.4.11.2. Rest
of Asia Pacific Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.11.3. Rest
of Asia Pacific Fiducial Markers Market, By Cancer Type, 2018-2029 (USD
Million) |
|
|
10.4.11.3. Rest
of Asia Pacific Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.5. Middle East & Africa |
|
|
10.4.1. Middle East &
Africa Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.2. Middle East &
AfricaFiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.3. Middle East &
Africa Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.4. Middle East &
Africa Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.5. Middle East &
Africa Fiducial Markers Market, By Country, 2018-2029 (USD Million) |
|
|
10.4.6. UAE |
|
|
10.4.6.1. UAE
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.6.2. UAE Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.6.3. UAE
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.6.3. UAE
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.7. Saudi Arabia |
|
|
10.4.7.1. Saudi
Arabia Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.7.2. Saudi
Arabia Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.7.3. Saudi
Arabia Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.7.3. Saudi Arabia
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.8. South Africa |
|
|
10.4.8.1. South
Africa Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.8.2. South
Africa Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.8.3. South
Africa Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.8.3. South
Africa Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.9. Rest of Middle East
& Africa |
|
|
10.4.9.1. Rest of
Middle East & Africa Fiducial Markers Market, By Product Type, 2018-2029
(USD Million) |
|
|
10.4.9.2. Rest of
Middle East & Africa Fiducial Markers Market, By Modality, 2018-2029 (USD
Million) |
|
|
10.4.9.3. Rest of
Middle East & Africa Fiducial Markers Market, By Cancer Type, 2018-2029
(USD Million) |
|
|
10.4.9.3. Rest of
Middle East & Africa Fiducial Markers Market, By End User, 2018-2029 (USD
Million) |
|
|
10.4. Latin America |
|
|
10.4.1. Latin America Fiducial
Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.2. Latin America Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.3. Latin America Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.4. Latin America Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.5. Latin America Fiducial Markers
Market, By Country, 2018-2029 (USD Million) |
|
|
10.4.6. Brazil |
|
|
10.4.6.1. Brazil
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.6.2. Brazil
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.6.3. Brazil
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.6.3. Brazil
Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.7. Mexico |
|
|
10.4.7.1. Mexico
Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.7.2. Mexico
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.7.3. Mexico
Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.7.3. Mexico Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.8. Argentina |
|
|
10.4.8.1.
Argentina Fiducial Markers Market, By Product Type, 2018-2029 (USD Million) |
|
|
10.4.8.2. Argentina
Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.8.3.
Argentina Fiducial Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
|
10.4.8.3.
Argentina Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.9. Rest of Latin America |
|
|
10.4.9.1. Rest of
Latin America Fiducial Markers Market, By Product Type, 2018-2029 (USD
Million) |
|
|
10.4.9.2. Rest of
Latin America Fiducial Markers Market, By Modality, 2018-2029 (USD Million) |
|
|
10.4.9.3. Rest of
Latin America Fiducial Markers Market, By Cancer Type, 2018-2029 (USD
Million) |
|
|
10.4.9.3. Rest of
Latin America Fiducial Markers Market, By End User, 2018-2029 (USD Million) |
|
|
Chapter 11. Competitive Landscape |
|
|
11.1. Market Revenue Share by Manufacturers |
|
|
11.2. Competitor’s Positioning |
|
|
11.3. Strategy Benchmarking |
|
|
11.3.1. Partnership &
Agreement |
|
|
11.3.2. New Product
Development |
|
|
11.3.3. Mergers & Acquisitions |
|
|
11.3.4. Investment &
Expansion |
|
|
11.4. Vendor Landscape |
|
|
11.4.1. Distributors |
|
|
11.4.2. North America |
|
|
11.4.3. Europe |
|
|
11.4.4. Asia Pacific |
|
|
11.4.5. Middle East &
Africa |
|
|
11.4.6. Latin America |
|
|
11.5. Zettabyte Analytics Insights for Competitive Landscape |
|
|
Chapter 12. Company Profiles |
|
|
12.1. Beekley Corporation |
|
|
12.1.1. Partnership &
Agreement |
|
|
12.1.2. New Product
Development |
|
|
12.1.3. Mergers &
Acquisitions |
|
|
12.1.4. Investment &
Expansion |
|
|
12.2. Best Medical International, Inc. |
|
|
12.2.1. Partnership &
Agreement |
|
|
12.2.2. New Product
Development |
|
|
12.2.3. Mergers &
Acquisitions |
|
|
12.2.4. Investment &
Expansion |
|
|
12.3. Boston Scientific Corporation |
|
|
12.3.1. Partnership &
Agreement |
|
|
12.3.2. New Product
Development |
|
|
12.3.3. Mergers &
Acquisitions |
|
|
12.3.4. Investment &
Expansion |
|
|
12.4. Carbon Medical Technologies |
|
|
12.4.1. Partnership &
Agreement |
|
|
12.4.2. New Product Development |
|
|
12.4.3. Mergers &
Acquisitions |
|
|
12.4.4. Investment &
Expansion |
|
|
12.5. CIVCO Radiotherapy |
|
|
12.5.1. Partnership &
Agreement |
|
|
12.5.2. New Product
Development |
|
|
12.5.3. Mergers &
Acquisitions |
|
|
12.5.4. Investment &
Expansion |
|
|
12.6. Eckert & Ziegler |
|
|
12.6.1. Partnership &
Agreement |
|
|
12.6.2. New Product
Development |
|
|
12.6.3. Mergers &
Acquisitions |
|
|
12.6.4. Investment &
Expansion |
|
|
12.7. IBA |
|
|
12.7.1. Partnership &
Agreement |
|
|
12.7.2. New Product
Development |
|
|
12.7.3. Mergers &
Acquisitions |
|
|
12.7.4. Investment & Expansion |
|
|
12.8. Innomedicus Ag |
|
|
12.8.1. Partnership &
Agreement |
|
|
12.8.2. New Product
Development |
|
|
12.8.3. Mergers &
Acquisitions |
|
|
12.8.4. Investment &
Expansion |
|
|
12.9.
Innovative Oncology Solutions |
|
|
12.9.1. Partnership &
Agreement |
|
|
12.9.2. New Product
Development |
|
|
12.9.3. Mergers &
Acquisitions |
|
|
12.9.4. Investment &
Expansion |
|
|
12.10. IZI Medical Products |
|
|
12.10.1. Partnership &
Agreement |
|
|
12.10.2. New Product
Development |
|
|
12.10.3. Mergers &
Acquisitions |
|
|
12.10.4. Investment &
Expansion |
|
|
12.11. JJ-Medtech |
|
|
12.11.1. Partnership &
Agreement |
|
|
12.11.2. New Product
Development |
|
|
12.11.3. Mergers &
Acquisitions |
|
|
12.11.4. Investment &
Expansion |
|
|
12.12. Meditronix Corporation |
|
|
12.12.1. Partnership &
Agreement |
|
|
12.12.2. New Product
Development |
|
|
12.12.3. Mergers &
Acquisitions |
|
|
12.12.4. Investment &
Expansion |
|
|
12.13. Medtronic |
|
|
12.13.1. Partnership &
Agreement |
|
|
12.13.2. New Product
Development |
|
|
12.13.3. Mergers &
Acquisitions |
|
|
12.13.4. Investment &
Expansion |
|
|
12.14. Nanovi A/S |
|
|
12.14.1. Partnership &
Agreement |
|
|
12.14.2. New Product
Development |
|
|
12.14.3. Mergers &
Acquisitions |
|
|
12.14.4. Investment &
Expansion |
|
|
12.15. Naslund Medical AB |
|
|
12.15.1. Partnership &
Agreement |
|
|
12.15.2. New Product Development |
|
|
12.15.3. Mergers &
Acquisitions |
|
|
12.15.4. Investment &
Expansion |
|
|
List of Tables |
|
|
1 |
Fiducial Markers Market, By Product Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
2 |
Metal-based Markers Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
3 |
Metal-based Markers Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
4 |
Polymer-based Markers Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
5 |
Polymer-based Markers Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
6 |
Other Fiducial Markers Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
7 |
Other Fiducial Markers Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
8 |
Fiducial Markers Market, By Modality
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
9 |
Fiducial Markers Market, By Cancer Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
10 |
Prostate Cancer Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
11 |
Prostate Cancer Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
12 |
Lung Cancer Market Estimates and Forecast,
2019-2029 (USD Million) |
|
13 |
Lung Cancer Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
14 |
Breast Cancer Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
15 |
Breast Cancer Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
16 |
Fiducial Markers Market, By End User
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
17 |
Hospitals & Outpatient Facilities
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
18 |
Hospitals & Outpatient Facilities
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
19 |
Independent Radiotherapy Centers Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
20 |
Independent Radiotherapy Centers Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
21 |
Cancer Research Centers Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
22 |
Cancer Research Centers Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
23 |
North America Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
24 |
North America Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
25 |
North America Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
26 |
North America Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
27 |
North America Fiducial Markers Market, By
Country, 2018-2029 (USD Million) |
|
28 |
U.S. Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
29 |
U.S. Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
30 |
U.S. Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
31 |
U.S. Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
32 |
Canada Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
33 |
Canada Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
34 |
Canada Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
35 |
Canada Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
36 |
Europe Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
37 |
Europe Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
38 |
Europe Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
39 |
EuropeFiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
40 |
Europe Fiducial Markers Market, By Country,
2018-2029 (USD Million) |
|
41 |
Germany Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
42 |
Germany Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
43 |
Germany Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
44 |
Germany Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
45 |
U.K. Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
46 |
U.K. Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
47 |
U.K. Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
48 |
U.K. Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
49 |
France Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
50 |
France Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
51 |
France Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
52 |
France Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
53 |
Spain Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
54 |
Spain Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
55 |
Spain Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
56 |
Spain Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
57 |
Italy Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
58 |
Italy Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
59 |
Italy Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
60 |
Italy Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
61 |
Rest of Europe Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
62 |
Rest of Europe Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
63 |
Rest of Europe Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
64 |
Rest of Europe Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
65 |
Asia Pacific Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
66 |
Asia Pacific Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
67 |
Asia Pacific Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
68 |
Asia Pacific Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
69 |
Asia Pacific Fiducial Markers Market, By
Country, 2018-2029 (USD Million) |
|
70 |
India Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
71 |
India Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
72 |
India Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
73 |
India Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
74 |
Japan Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
75 |
Japan Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
76 |
Japan Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
77 |
Japan Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
78 |
China Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
79 |
China Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
80 |
China Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
81 |
China Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
82 |
South Korea Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
83 |
South Korea Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
84 |
South Korea Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
85 |
South Korea Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
86 |
Australia Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
87 |
Australia Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
88 |
Australia Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
89 |
Australia Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
90 |
Rest of Asia Pacific Fiducial Markers
Market, By Product Type, 2018-2029 (USD Million) |
|
91 |
Rest of Asia Pacific Fiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
92 |
Rest of Asia Pacific Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
93 |
Rest of Asia Pacific Fiducial Markers
Market, By End User, 2018-2029 (USD Million) |
|
94 |
Middle East & Africa Fiducial Markers
Market, By Product Type, 2018-2029 (USD Million) |
|
95 |
Middle East & AfricaFiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
96 |
Middle East & Africa Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
97 |
Middle East & Africa Fiducial Markers
Market, By End User, 2018-2029 (USD Million) |
|
98 |
Middle East & Africa Fiducial Markers
Market, By Country, 2018-2029 (USD Million) |
|
99 |
UAE Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
100 |
UAE Fiducial Markers Market, By Modality,
2018-2029 (USD Million) |
|
101 |
UAE Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
102 |
UAE Fiducial Markers Market, By End User,
2018-2029 (USD Million) |
|
103 |
Saudi Arabia Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
104 |
Saudi Arabia Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
105 |
Saudi Arabia Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
106 |
Saudi Arabia Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
107 |
South Africa Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
108 |
South Africa Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
109 |
South Africa Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
110 |
South Africa Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
111 |
Rest of Middle East & Africa Fiducial
Markers Market, By Product Type, 2018-2029 (USD Million) |
|
112 |
Rest of Middle East & Africa Fiducial
Markers Market, By Modality, 2018-2029 (USD Million) |
|
113 |
Rest of Middle East & Africa Fiducial
Markers Market, By Cancer Type, 2018-2029 (USD Million) |
|
114 |
Rest of Middle East & Africa Fiducial
Markers Market, By End User, 2018-2029 (USD Million) |
|
115 |
Latin America Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
116 |
Latin America Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
117 |
Latin America Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
118 |
Latin America Fiducial Markers Market, By
End User, 2018-2029 (USD Million) |
|
119 |
Latin America Fiducial Markers Market, By
Country, 2018-2029 (USD Million) |
|
120 |
Brazil Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
121 |
Brazil Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
122 |
Brazil Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
123 |
Brazil Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
124 |
Mexico Fiducial Markers Market, By Product
Type, 2018-2029 (USD Million) |
|
125 |
Mexico Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
126 |
Mexico Fiducial Markers Market, By Cancer
Type, 2018-2029 (USD Million) |
|
127 |
Mexico Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
128 |
Argentina Fiducial Markers Market, By
Product Type, 2018-2029 (USD Million) |
|
129 |
Argentina Fiducial Markers Market, By
Modality, 2018-2029 (USD Million) |
|
130 |
Argentina Fiducial Markers Market, By
Cancer Type, 2018-2029 (USD Million) |
|
131 |
Argentina Fiducial Markers Market, By End
User, 2018-2029 (USD Million) |
|
132 |
Rest of Latin America Fiducial Markers
Market, By Product Type, 2018-2029 (USD Million) |
|
133 |
Rest of Latin America Fiducial Markers
Market, By Modality, 2018-2029 (USD Million) |
|
134 |
Rest of Latin America Fiducial Markers
Market, By Cancer Type, 2018-2029 (USD Million) |
|
135 |
Rest of Latin America Fiducial Markers
Market, By End User, 2018-2029 (USD Million) |
|
136 |
Product Launch & Development in The
Fiducial Markers Market, 2018-2021 |
|
137 |
Investment & Expansion in The Fiducial
Markers Market, 2018-2021 |
|
138 |
Partnership & Collaboration in The
Fiducial Markers Market, 2018-2021 |
|
139 |
Merger & Acquisition in The Fiducial
Markers Market, 2018-2021 |
|
List of Figures |
|
|
1 |
Research Methodology |
|
2 |
Summary Snapshot Market Size and Forecast,
USD Million, 2021 & 2029 |
|
3 |
Global Fiducial Markers Market Segmentation
& Impact Analysis |
|
4 |
Regulatory Analysis |
|
5 |
COVID-19 Impact analysis on Fiducial
Markers Market |
|
6 |
Market Revenue Share by Manufacturers |
|
7 |
Fiducial Markers Market, By Product Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
8 |
Fiducial Markers Market, By Modality
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
9 |
Fiducial Markers Market, By Cancer Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
10 |
Fiducial Markers Market, By End User
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
11 |
Fiducial Markers Market, By Region (Market
Size and Forecast by Value - USD Million, 2021 & 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States